Comments
Loading...

Mineralys Therapeutics

MLYSNASDAQ
$13.89
-0.69-4.73%
At Close: -
$13.89
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed

Mineralys Therapeutics (NASDAQ:MLYS) Stock, Earnings Estimates, EPS, And Revenue

Mineralys Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 9
EPS
$-0.700
Quarterly Revenue
$0K
Annual Revenue
(as of Mar 31)

Analyze the earnings history of Mineralys Therapeutics using advanced sorting and filters.

Get Alert
MLYS
Mineralys Therapeutics
-$0.31$0.0008/05/2024Get Alert
MLYS
Mineralys Therapeutics
-$0.51-$0.67-$0.70-4.48%$0.00$0.0005/09/2024Get Alert
MLYS
Mineralys Therapeutics
-$1.74-$0.82-$0.6125.61%$0.00$0.0003/21/2024Get Alert
MLYS
Mineralys Therapeutics
-$1.29-$0.76-$0.5725.00%$0.0011/07/2023Get Alert
MLYS
Mineralys Therapeutics
-$1.26-$0.83-$0.3162.65%$0.00$0.0008/07/2023Get Alert
MLYS
Mineralys Therapeutics
-$1.48-$0.89-$0.5142.70%$0.00$0.0005/15/2023Get Alert
MLYS
Mineralys Therapeutics
-$1.72-$1.74-1.16%$0.0003/15/2023Get Alert

Mineralys Therapeutics (MLYS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Mar 20242024-05-09$-0.70$-0.67-4.48 %
Dec 20232024-03-21$-0.61$-0.8225.6 %
Sep 20232023-11-07$-0.57$-0.7625.0 %
Jun 20232023-08-07$-0.31$-0.8362.6 %

Mineralys Therapeutics (MLYS) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Mineralys Therapeutics (NASDAQ:MLYS) reporting earnings?

A

Mineralys Therapeutics (MLYS) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for Mineralys Therapeutics (NASDAQ:MLYS)?

A

The Actual EPS was $-0.70, which missed the estimate of $-0.67.

Q

What were Mineralys Therapeutics’s (NASDAQ:MLYS) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch